2,6-Bis((2-((R)-4-phenyl-4,5-dihydrooxazol-2-yl)phenoxy)methyl)pyridine

Catalog No. :
ACZOGW125
CAS No. :
850533-56-1
Molecular Formula :
C37H31N3O4
Molecular Weight :
581.67

IUPAC Name:2,6-bis((2-((R)-4-phenyl-4,5-dihydrooxazol-2-yl)phenoxy)methyl)pyridine

2,6-Bis((2-((R)-4-phenyl-4,5-dihydrooxazol-2-yl)phenoxy)methyl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,6-Bis((2-((R)-4-phenyl-4,5-dihydrooxazol-2-yl)phenoxy)methyl)pyridine
IUPAC Name2,6-bis((2-((R)-4-phenyl-4,5-dihydrooxazol-2-yl)phenoxy)methyl)pyridine
Molecular FormulaC37H31N3O4
Molecular Weight581.67
SMILESC1(COC2=CC=CC=C2C3=N[C@H](C4=CC=CC=C4)CO3)=NC(COC5=CC=CC=C5C6=N[C@H](C7=CC=CC=C7)CO6)=CC=C1
InChI KeySQKVGMGKNYAZDR-LQJZCPKCSA-N
SynonymPyridine, 2,6-bis[[2-[(4R)-4,5-dihydro-4-phenyl-2-oxazolyl]phenoxy]methyl]-;2,6-Bis[[2-[(4R)-4,5-dihydro-4-phenyl-2-oxazolyl]phenoxy]methyl]pyridine
CAS No.850533-56-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZOGW125 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZVGU183 route compound structure diagram
    ACZVGU183150699-08-4 In Stock
  4. Then
  5. ACZOGW125 route product structure diagram
    ACZOGW125850533-56-1
Inquiry

2. ACZOGW125 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZVGU183 route compound structure diagram
    ACZVGU183150699-08-4 In Stock
  4. Then
  5. ACZOGW125 route product structure diagram
    ACZOGW125850533-56-1
Inquiry

Comments (0)